Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 56% ± 20% | |
peripheral blood | 19 studies | 42% ± 12% | |
intestine | 14 studies | 38% ± 16% | |
kidney | 9 studies | 45% ± 14% | |
eye | 8 studies | 33% ± 14% | |
brain | 7 studies | 34% ± 12% | |
lymph node | 7 studies | 39% ± 19% | |
liver | 7 studies | 41% ± 16% | |
uterus | 6 studies | 53% ± 20% | |
placenta | 5 studies | 53% ± 29% | |
pancreas | 4 studies | 70% ± 21% | |
bone marrow | 4 studies | 35% ± 17% | |
esophagus | 4 studies | 69% ± 27% | |
prostate | 4 studies | 47% ± 16% | |
breast | 4 studies | 48% ± 7% | |
ovary | 3 studies | 34% ± 10% | |
adrenal gland | 3 studies | 42% ± 7% | |
thymus | 3 studies | 47% ± 20% | |
skin | 3 studies | 55% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 5578.14 | 170 / 170 | 100% | 515.96 | 459 / 459 |
thymus | 100% | 5998.66 | 653 / 653 | 100% | 176.91 | 602 / 605 |
skin | 100% | 8420.90 | 1809 / 1809 | 99% | 263.94 | 467 / 472 |
intestine | 100% | 4803.32 | 965 / 966 | 99% | 216.69 | 521 / 527 |
ovary | 100% | 4185.83 | 180 / 180 | 99% | 150.40 | 424 / 430 |
lung | 100% | 9214.70 | 578 / 578 | 99% | 322.01 | 1138 / 1155 |
bladder | 100% | 10156.86 | 21 / 21 | 98% | 443.06 | 495 / 504 |
prostate | 100% | 5146.56 | 245 / 245 | 98% | 100.69 | 492 / 502 |
breast | 100% | 6216.33 | 459 / 459 | 98% | 153.11 | 1094 / 1118 |
esophagus | 100% | 142585.42 | 1444 / 1445 | 98% | 446.86 | 179 / 183 |
stomach | 99% | 4063.08 | 355 / 359 | 98% | 157.04 | 281 / 286 |
brain | 100% | 3903.34 | 2630 / 2642 | 95% | 77.37 | 673 / 705 |
kidney | 100% | 5549.21 | 89 / 89 | 95% | 117.08 | 854 / 901 |
adrenal gland | 100% | 6972.84 | 258 / 258 | 94% | 90.99 | 216 / 230 |
liver | 99% | 5629.38 | 223 / 226 | 91% | 103.94 | 369 / 406 |
pancreas | 82% | 1668.13 | 268 / 328 | 98% | 231.43 | 175 / 178 |
adipose | 100% | 7195.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 199.99 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 206.52 | 29 / 29 |
spleen | 100% | 4441.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 766.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 405.75 | 1 / 1 |
blood vessel | 99% | 4761.58 | 1327 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5508.96 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 3356.17 | 833 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 2176.42 | 744 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008344 | Biological process | adult locomotory behavior |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0010466 | Biological process | negative regulation of peptidase activity |
GO_0005730 | Cellular component | nucleolus |
GO_0005615 | Cellular component | extracellular space |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0002020 | Molecular function | protease binding |
GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | CSTB |
Protein name | Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B) Cystatin-B (Stefin-B) Cystatin B |
Synonyms | CST6 hCG_401291 STFB |
Description | FUNCTION: This is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B. FUNCTION: This is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B. . FUNCTION: This is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B. . |
Accessions | P04080 ENST00000639959.1 A0A1W2PQG6 ENST00000291568.7 ENST00000640406.1 Q76LA1 A0A1W2PS52 |